Your browser doesn't support javascript.
loading
Ravoxertinib Improves Long-Term Neurologic Deficits after Experimental Subarachnoid Hemorrhage through Early Inhibition of Erk1/2.
Yang, Ming-Feng; Sun, Sheng-Yao; Lv, Hai-Guang; Wang, Wei-Qi; Li, Han-Xia; Sun, Jing-Yi; Zhang, Zong-Yong.
Afiliación
  • Yang MF; Department of Neurology, Second Affiliated Hospital, Shandong First Medical University & Shandong Academy of Medical Sciences, Tai'an 271016 Shandong, People's Republic of China.
  • Sun SY; Department of Neurology, Second Affiliated Hospital, Shandong First Medical University & Shandong Academy of Medical Sciences, Tai'an 271016 Shandong, People's Republic of China.
  • Lv HG; Department of Neurology, Second Affiliated Hospital, Shandong First Medical University & Shandong Academy of Medical Sciences, Tai'an 271016 Shandong, People's Republic of China.
  • Wang WQ; Shandong Provincial Hospital Affiliated to Shandong First Medical University, Ji'nan 250021, Shandong, People's Republic of China.
  • Li HX; Department of Neurology, Second Affiliated Hospital, Shandong First Medical University & Shandong Academy of Medical Sciences, Tai'an 271016 Shandong, People's Republic of China.
  • Sun JY; Shandong Provincial Hospital Affiliated to Shandong First Medical University, Ji'nan 250021, Shandong, People's Republic of China.
  • Zhang ZY; Department of Neurology, Second Affiliated Hospital, Shandong First Medical University & Shandong Academy of Medical Sciences, Tai'an 271016 Shandong, People's Republic of China.
ACS Omega ; 8(22): 19692-19704, 2023 Jun 06.
Article en En | MEDLINE | ID: mdl-37305289

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: ACS Omega Año: 2023 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: ACS Omega Año: 2023 Tipo del documento: Article